ASCO 2020: Novel IL-12 Activation Gene Therapy Shows Promise in Combination With Nivolumab
No concerning safety signals were observed, and there were signs of anti-tumor effects
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.